MENOTROPIN 75 IU
Menotropin contains a combination of follicle stimulating hormone and luteinising hormone activity. It is used to directly stimulate the testes in order to support spermatogenesis and overall reproductive function. In performance and recovery environments Menotropin is valued for its role in fertility support and advanced hormonal recovery where deeper testicular stimulation is required beyond basic luteinising hormone mimetics.
Menotropin contains a combination of follicle stimulating hormone and luteinising hormone activity. It is used to directly stimulate the testes in order to support spermatogenesis and overall reproductive function. In performance and recovery environments Menotropin is valued for its role in fertility support and advanced hormonal recovery where deeper testicular stimulation is required beyond basic luteinising hormone mimetics.
Properties and Effects
- Stimulates sperm production through FSH activity
- Supports testicular function and fertility restoration
- Enhances intratesticular hormone signalling
- Useful in advanced recovery or fertility focused protocols
- Complements other hormonal support compounds
Chemical Structure Model
Mechanism of Action
Menotropin delivers both follicle stimulating hormone and luteinising hormone activity directly to the testes. FSH stimulates the Sertoli cells which are responsible for sperm maturation while LH activity supports testosterone production through Leydig cell activation. This dual mechanism makes Menotropin effective for restoring full reproductive function rather than testosterone output alone.
Recommended Use
Menotropin is typically used in structured fertility or advanced recovery protocols. It may be combined with other hormonal support compounds depending on the objective. Proper timing dosage and medical oversight are important to ensure effectiveness and safety. Adequate nutrition rest and overall health management enhance outcomes.
Safety and Side Effects
Possible side effects include water retention mood changes injection site discomfort or hormonal fluctuations. Excessive stimulation may cause testicular discomfort or estrogen elevation secondary to increased testosterone production. Individuals with hormone sensitive conditions should use caution. Not recommended during pregnancy or breastfeeding unless medically directed.
Special Notes
Menotropin is primarily a fertility focused compound rather than a muscle building agent. Its value lies in restoring full reproductive axis functionality. Blood work monitoring is recommended when used in recovery or fertility planning to guide appropriate use and duration.
Recommended dosage
- 75 IU to 150 IU per dose
- Typical use is 75 IU taken two to three times per week
Timing of doses
- Administer on non consecutive days
- Keep dosing on consistent days each week
Practical guidance
Menotropin is used to support gonadotropin activity and is typically introduced conservatively. Consistent scheduling is more important than time of day. Dosage is often adjusted based on individual response, so starting at the lower end is preferred. Monitoring and defined use periods are recommended rather than continuous long term use.
Estimated Degradation
Model classification
Moderate to lower stability, more caution warranted than for many smaller simple peptides.
Evidence strength
Moderate for actual post reconstitution handling, strong for general biologic hormone stability reasoning.
Assumption used
For this model only, reconstituted with bacteriostatic water and stored refrigerated at 2 to 8 degrees Celsius, protected from light, minimal agitation.
Estimated degradation model for MENOTROPIN
| Time after mixing | Estimated remaining potency | Estimated degradation |
| 1 week | 93% | 7% |
| 2 weeks | 84% | 16% |
| 3 weeks | 74% | 26% |
| 4 weeks | 63% | 37% |
| 5 weeks | 51% | 49% |
| 6 weeks | 38% | 62% |
Using Peptide Injectable Vials

STEP 1:VERIFY VIAL INTEGRITY
Inspect both the peptide vial and the bacteriostatic water vial carefully. Check that the caps and seals are intact and have not been tampered with. The contents should appear clear, with no visible particles, cloudiness, or contamination before proceeding.

IMPORTANTINSPECT THE LID
Check both the peptide vial and the bacteriostatic water vial. Locate the small arrows stamped into the gold seal, which indicate the correct opening point. The seal should be opened from the side the arrows point to for proper removal.

STEP 2:LIFT PROTECTIVE CAPS
Gently lift the clear plastic protective cap from the top of the vial. This exposes the gold aluminium safety seal underneath. Take care not to bend or damage the metal seal while removing the plastic cap.

STEP 3:BREAK OFF SAFETY TABS
While lifting the plastic cap from the side indicated by the arrows, gently wiggle it left and right until the small metal tear tab snaps. This opens the seal correctly and exposes the rubber stopper without removing the entire aluminium ring.

IMPORTANTMETAL SEAL REMOVED
The gold metal seal should be lifted from the side indicated by the arrows, leaving the rubber stopper clearly visible. The opening should appear clean and unobstructed, with the metal seal removed evenly and without bending into the centre of the vial.

STEP 4:ADD BACTERIOSTATIC WATER
Insert the syringe needle into the bacteriostatic water vial and draw the required amount of liquid. Slowly inject the water into the peptide vial, allowing the liquid to run down the inner wall of the vial to help protect the peptide.

STEP 5:DISSOLVE THE PEPTIDE
Gently roll or spin the vial between your fingers until the peptide is completely dissolved. Do not shake the vial, as vigorous shaking may damage the peptide structure and reduce its stability.

STEP 6:MEASURE REQUIRED DOSE
Insert the syringe into the vial and draw the required dose through the rubber stopper. Store the mixed solution in a refrigerator and use it within 30 days after mixing.
Additional Product Information
| Product Name | MENOTROPIN 75 IU |
|---|---|
| Also Known As | hMG, Human menopausal gonadotropin, Menotropin, Menotropins |
| Product Stock Code | VM-PL-HMG-75-1 |
| Categories | Anti Estrogens and Post Cycle Treatments (PCT's), Peptides / Growth Hormones |
| Contents | HUMAN MENOPAUSAL GONADOTROPIN |
| Presentation Size | 75 IU per bottle |
| Strength | 20 mg per box |
More Information
Please login to view more






